pentobarbital will lower the level or outcome of gefitinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism.Following halting a CYP3A4 inducer, given that the effects in the inducer decline, the fentanyl plasma focus will increase which could improve or extend both the therapeutic and adverse effects.pentobarbital will minimize the extent o